Avis de convocation à l’assemblée générale 2024 des actionnaires ONWARD® et propositions de résolutions
02 mai 2024 21h31 HE
|
ONWARD Medical NV
EINDHOVEN, Pays-Bas, 03 mai 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société de technologie médicale à l’origine de thérapies innovantes ciblées sur la restauration du...
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
02 mai 2024 01h00 HE
|
ONWARD Medical NV
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
ONWARD® Medical annonce ses résultats financiers et opérationnels pour l’exercice 2023 et partage les faits qui ont marqué l’exercice 2024 à ce jour
26 avr. 2024 09h17 HE
|
ONWARD Medical NV
Dépôt auprès de la FDA d’une demande de classification du dispositif ARC-EX® System basée sur les risques (demande « De Novo ») Levée de fonds de 20 millions d’euros Annonce des résultats...
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
25 avr. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Reports Full Year 2023 Financial and Operating Results and Shares 2024 Highlights Year-to-Date
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
11 avr. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD® Medical Announces Publication of Full Year 2023 Financial Results and Business Update Webcast
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
09 avr. 2024 01h00 HE
|
ONWARD Medical NV
Stifel Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 12.00
ONWARD® Medical Submits De Novo Application to FDA for its ARC-EX® System
02 avr. 2024 01h30 HE
|
ONWARD Medical NV
ONWARD Medical has submitted its De Novo application to the US Food and Drug Administration (FDA) to allow marketing of its breakthrough ARC-EX System.
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
25 mars 2024 12h40 HE
|
ONWARD Medical NV
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
ONWARD® Medical Publishes Prospectus for Listing of New Shares
21 mars 2024 13h26 HE
|
ONWARD Medical NV
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL....
ONWARD® Medical Lève avec Succès 20 millions d'euros dans le cadre d'une Augmentation de Capital par le biais d'une Procédure de Construction Accélérée d'un Livre d'Ordres et d'une Offre au Public en France
20 mars 2024 22h03 HE
|
ONWARD Medical NV
NE PAS DISTRIBUER OU DIFFUSER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS, AU CANADA, EN AUSTRALIE OU AU JAPON OU DANS TOUTE AUTRE JURIDICTION DANS LAQUELLE LA DISTRIBUTION OU LA DIFFUSION SERAIT...